Urology
Volume 73, Issue 2 , Pages 220-224 , February 2009

Is There Evidence for a Role of Propionibacterium acnes in Prostatic Disease?

  • Oleg Alexeyev

      Affiliations

    • Department of Medical Biosciences, Umeå University, Umeå, Sweden
    • Corresponding Author InformationReprint requests: Oleg Alexeyev, M.D., Ph.D., Department of Medical Biosciences, Umeå University, Umeå SE-901 87 Sweden
    • ,
  • Jan Olsson

      Affiliations

    • Department of Medical Biosciences, Umeå University, Umeå, Sweden
    • ,
  • Fredrik Elgh

      Affiliations

    • Department of Medical Biosciences, Umeå University, Umeå, Sweden
    • Department of Clinical Medicine, Örebro University School of Health and Medical Sciences, Örebro, Sweden

Received 25 January 2008 ,Accepted 20 February 2008.

References 

  1. De Marzo AM, Platz EA, Sutcliffe S, et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer. 2007;7:256–269
  2. Konig JE, Senge T, Allhoff EP, et al. Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer. Prostate. 2004;58:121–129
  3. Kramer G, Marberger M. Could inflammation be a key component in the progression of benign prostatic hyperplasia?. Curr Opin Urol. 2006;16:25–29
  4. Sciarra A, Di Silverio F, Salciccia S, et al. Inflammation and chronic prostatic diseases: evidence for a link?. Eur Urol. 2007;52:964–972
  5. Cohen RJ, Shannon BA, McNeal JE, et al. Propionibacterium acnes associated with inflammation in radical prostatectomy specimens: a possible link to cancer evolution?. J Urol. 2005;173:1969–1974
  6. Bruggemann H, Henne A, Hoster F, et al. The complete genome sequence of Propionibacterium acnes, a commensal of human skin. Science. 2004;305:671–673
  7. McDowell A, Perry AL, Lambert PA, et al. A new phylogenetic group of Propionibacterium acnes. J Med Microbiol. 2008;57:218–224
  8. McDowell A, Valanne S, Ramage G, et al. Propionibacterium acnes types I and II represent phylogenetically distinct groups. J Clin Microbiol. 2005;43:326–334
  9. Brook I, Frazier EH. Infections caused by Propionibacterium species. Rev Infect Dis. 1991;13:819–822
  10. Esteban J, Garcia-Calvo G, Jimenez-Castillo P, et al. Failure of Gram stain to detect Propionibacterium acnes in specimens from clinically significant infections. J Clin Microbiol. 1996;34:2051
  11. Amann RI, Ludwig W, Schleifer KH. Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol Rev. 1995;59:143–169
  12. Tunney MM, Patrick S, Curran MD, et al. Detection of prosthetic hip infection at revision arthroplasty by immunofluorescence microscopy and PCR amplification of the bacterial 16S rRNA gene. J Clin Microbiol. 1999;37:3281–3290
  13. Yamada T, Eishi Y, Ikeda S, et al. In situ localization of Propionibacterium acnes DNA in lymph nodes from sarcoidosis patients by signal amplification with catalysed reporter deposition. J Pathol. 2002;198:541–547
  14. Alexeyev OA, Marklund I, Shannon B, et al. Direct visualization of Propionibacterium acnes in prostate tissue by multicolor fluorescent in situ hybridization assay. J Clin Microbiol. 2007;45:3721–3728
  15. Sfanos KS, Sauvageot J, Fedor HL, et al. A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms. Prostate. 2008;68:306–320
  16. Alexeyev O, Bergh J, Marklund I, et al. Association between the presence of bacterial 16S RNA in prostate specimens taken during transurethral resection of prostate and subsequent risk of prostate cancer (Sweden). Cancer Causes Control. 2006;17:1127–1133
  17. Shiina H, Himeno Y, Ishibe T. Organisms in the prostate and antibiotics in the treatment of postoperative infections. Urol Int. 1992;48:187–190
  18. Nickel JC, Downey J, Young I, et al. Asymptomatic inflammation and/or infection in benign prostatic hyperplasia. BJU Int. 1999;84:976–981
  19. Lee JC, Muller CH, Rothman I, et al. Prostate biopsy culture findings of men with chronic pelvic pain syndrome do not differ from those of healthy controls. J Urol. 2003;169:584–588
  20. Berger RE, Krieger JN, Rothman I, et al. Bacteria in the prostate tissue of men with idiopathic prostatic inflammation. J Urol. 1997;157:863–865
  21. Lindert KA, Kabalin JN, Terris MK. Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. J Urol. 2000;164:76–80
  22. Hochreiter WW, Duncan JL, Schaeffer AJ. Evaluation of the bacterial flora of the prostate using a 16S rRNA gene based polymerase chain reaction. J Urol. 2000;163:127–130
  23. Krieger JN, Riley DE, Vesella RL, et al. Bacterial DNA sequences in prostate tissue from patients with prostate cancer and chronic prostatitis. J Urol. 2000;164:1221–1228
  24. Keay S, Zhang CO, Baldwin BR, et al. Polymerase chain reaction amplification of bacterial 16s rRNA genes in prostate biopsies from men without chronic prostatitis. Urology. 1999;53:487–491
  25. Leskinen MJ, Rantakokko-Jalava K, Manninen R, et al. Negative bacterial polymerase chain reaction (PCR) findings in prostate tissue from patients with symptoms of chronic pelvic pain syndrome (CPPS) and localized prostate cancer. Prostate. 2003;55:105–110
  26. Sznol M, Lin SL, Bermudes D, et al. Use of preferentially replicating bacteria for the treatment of cancer. J Clin Invest. 2000;105:1027–1030
  27. Galobardes B, Davey Smith G, Jeffreys M, et al. Acne in adolescence and cause-specific mortality: lower coronary heart disease but higher prostate cancer mortality: the Glasgow Alumni Cohort study. Am J Epidemiol. 2005;161:1094–1101
  28. Sutcliffe S, Giovannucci E, Isaacs WB, et al. Acne and risk of prostate cancer. Int J Cancer. 2007;121:2688–2692
  29. Shannon BA, Cohen RJ, Garrett KL. The antibody response to Propionibacterium acnes is an independent predictor of serum prostate-specific antigen levels in biopsy-negative men. BJU Int. 2007;101:429–435
  30. Tanner MA, Shoskes D, Shahed A, et al. Prevalence of Corynebacterium 16S rRNA sequences in patients with bacterial and “nonbacterial” prostatitis. J Clin Microbiol. 1999;37:1863–1870
  31. Willen M, Holst E, Myhre EB, et al. The bacterial flora of the genitourinary tract in healthy fertile men. Scand J Urol Nephrol. 1996;30:387–393
  32. Shannon BA, Cohen RJ, Garrett KL. Polymerase chain reaction-based identification of Propionibacterium acnes types isolated from the male urinary tract: evaluation of adolescents, normal adults and men with prostatic pathology. BJU Int. 2006;98:388–392
  33. Kuwata K, Watanabe H, Jiang SY, et al. AIM inhibits apoptosis of T cells and NKT cells in Corynebacterium-induced granuloma formation in mice. Am J Pathol. 2003;162:837–847
  34. Webster GF, Leyden JJ, Musson RA, et al. Susceptibility of Propionibacterium acnes to killing and degradation by human neutrophils and monocytes in vitro. Infect Immun. 1985;49:116–121
  35. Costerton W, Veeh R, Shirtliff M, et al. The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest. 2003;112:1466–1477
  36. Coenye T, Peeters E, Nelis HJ. Biofilm formation by Propionibacterium acnes is associated with increased resistance to antimicrobial agents and increased production of putative virulence factors. Res Microbiol. 2007;158:386–392
  37. Ramage G, Tunney MM, Patrick S, et al. Formation of Propionibacterium acnes biofilms on orthopaedic biomaterials and their susceptibility to antimicrobials. Biomaterials. 2003;24:3221–3227
  38. Nickel JC, Costerton JW. Bacterial localization in antibiotic-refractory chronic bacterial prostatitis. Prostate. 1993;23:107–114
  39. Chen YL, Yu CK, Lei HY. Propionibacterium acnes induces acute TNF-alpha-mediated apoptosis of hepatocytes followed by inflammatory T-cell-mediated granulomatous hepatitis in mice. J Biomed Sci. 1999;6:349–356
  40. Graham GM, Farrar MD, Cruse-Sawyer JE, et al. Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P. acnes GroEL. Br J Dermatol. 2004;150:421–428
  41. Nagy I, Pivarcsi A, Kis K, et al. Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect. 2006;8:2195–2205
  42. Schaller M, Loewenstein M, Borelli C, et al. Induction of a chemoattractive proinflammatory cytokine response after stimulation of keratinocytes with Propionibacterium acnes and coproporphyrin III. Br J Dermatol. 2005;153:66–71
  43. Vowels BR, Yang S, Leyden JJ. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun. 1995;63:3158–3165
  44. Jugeau S, Tenaud I, Knol AC, et al. Induction of toll-like receptors by Propionibacterium acnes. Br J Dermatol. 2005;153:1105–1113
  45. Kalis C, Gumenscheimer M, Freudenberg N, et al. Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnes. J Immunol. 2005;174:4295–4300
  46. Kundu SD, Lee C, Billips BK, et al. The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells. Prostate. 2008;68:223–229
  47. Zheng SL, Augustsson-Balter K, Chang B, et al. Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study. Cancer Res. 2004;64:2918–2922
  48. Gerstner GJ, Grunberger W, Boschitsch E, et al. Vaginal organisms in prepubertal children with and without vulvovaginitis: a vaginoscopic study. Arch Gynecol. 1982;231:247–252
  49. Thomason JL, Schreckenberger PC, Spellacy WN, et al. Clinical and microbiological characterization of patients with nonspecific vaginosis associated with motile, curved anaerobic rods. J Infect Dis. 1984;149:801–809
  50. Persson E, Holmberg K. A longitudinal study of Actinomyces israelii in the female genital tract. Acta Obstet Gynecol Scand. 1984;63:207–216

PII: S0090-4295(08)00267-7

doi: 10.1016/j.urology.2008.02.052

Urology
Volume 73, Issue 2 , Pages 220-224 , February 2009

Article Tools

* Image Usage & Resolution